INS and polycystic ovary syndrome: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women affecting 4-10% of those of reproductive age.[1, 2] PCOS is characterized by hyperandrogenism, insulin insensitivity, and chronic anovulation.[3] Research over the last few decades has established that PCOS is an important metabolic disorder, associated with an increased risk of T2DM as well as metabolic syndrome.[4] It has been proposed women who have mild hyperandrogenism and an isolated ultrasonic finding of polycystic ovaries but whose ovulatory function is maintained exhibit a mild form of PCOS.